Global Therapies and Diagnostics for Ovarian Cancer Market is Estimated to Reach $4 Billion by 2025, Says Accurize Market Research
Global Therapies and Diagnostics for Ovarian Cancer Market report published by Accurize Market Research forecast that the global market is expected to reach $4 billion by 2025; growing at a CAGR of 7.2% from 2017 to 2025. By geography, Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.
To browse the complete report, visit at https://www.accurizemarketresearch.com/report/therapies-and-diagnostics-for-ovarian-cancer-marke
Increasing research and development activities, increasing elderly population across the globe and technological advancements in therapies and diagnostics for ovarian cancer fuels the market
Increasing research and development activities, increasing elderly population across the globe and technological advancements in therapies and diagnostics for ovarian cancer and growing healthcare expenditure fuel the demand for the global therapies and diagnostics for ovarian cancer market. Furthermore, growth in healthcare infrastructure and increased government funding also boosts the growth of the market.
The global therapies and diagnostics for ovarian cancer market have been bifurcated on the basis of diagnosis, cancer type and geography. Diagnosis segment is segmented into physical examination, biopsy, blood tests, human chorionic gonadotropin (HCG) test, ultrasound, CT scan and others. Cancer type segment is further segmented into epithelial ovarian tumors, germ cell tumors, stromal tumors, primary peritoneal cancer, stages of ovarian cancer and prognosis. By geography the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Top players in the market
The key players operational in the market includes Abbvie Inc., Astra Zeneca, Bristol-Myers Squibb, Celgene Corp., Clovis Oncology, Eli Lilly And Company, GlaxoSmithKline Plc., Hikma Pharmaceuticals Plc., Janssen Pharmaceuticals Inc., Merck & Co. Inc., Myriad Genetics Inc., Novartis Ag, Pfizer Inc., Quest Diagnostics Inc., Roche Holding Ag And Tesaro Inc. among others.
Head - Sales
Accurize Market Research
K-129, PC COLONY, HANUMAN NAGAR,